Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05820412 · ClinicalTrials.gov registry record
Individualized Assessment of Motor Function and Balance in Intensive Therapy
A clinical trial, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- 4
- Enrollment target
NCT05820412: Completed study, sponsored by University of Missouri-Columbia.
NCT05820412 is a clinical trial that has completed, run by University of Missouri-Columbia. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05820412 has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The goal of this study is to assess the individualized use of technology to assess motor function and balance for ambulatory children participating in an intensive therapy episode of care and determine the effectiveness of the program. Children 7-17 years old who can walk and are completing an intensive therapy episode of care will be recruited to participate in this study. Demographic, health history, and PT,OT,ST medical records will be collected. Based on the participant's functional goals, motor function and balance tests will be selected including common balance tests (standing with eyes open, standing with eyes closed), walking, walking and turning, standing up and sitting down from a bench, reaction time, and step down. Participants will be tested before, immediately after, 6 weeks after, and 12 weeks after the episode of care.
Primary Outcome
center of pressure as a measure of postural control obtained from a forceplate obtained while eyes closed standing on firm surface
Interventions
- OTHER Intensive interdisciplinary therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2023-05-22 |
| Est. Completion | 2023-12-31 |
What the finished NCT05820412 record still lists
NCT05820412 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Intensive interdisciplinary therapy is the first listed.
NCT05820412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05820412 about?
NCT05820412 is a clinical study titled "Individualized Assessment of Motor Function and Balance in Intensive Therapy". The goal of this study is to assess the individualized use of technology to assess motor function and balance for ambulatory children participating in an intensive therapy episode of care and determine the effectiveness of the program. Children 7-17 years old who can walk and are completing an inten...
What is the current status of trial NCT05820412?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2023-05-22. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05820412?
The interventions under investigation include: Intensive interdisciplinary therapy (OTHER).
Who is sponsoring clinical trial NCT05820412?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI